| Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease CJ Azevedo, SY Cen, S Khadka, S Liu, J Kornak, Y Shi, L Zheng, ... Annals of neurology 83 (2), 223-234, 2018 | 248 | 2018 |
| Myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and myelitis in COVID-19 S Zhou, EC Jones-Lopez, DJ Soneji, CJ Azevedo, VR Patel Journal of Neuro-Ophthalmology 40 (3), 398-402, 2020 | 233 | 2020 |
| Early CNS neurodegeneration in radiologically isolated syndrome CJ Azevedo, E Overton, S Khadka, J Buckley, S Liu, M Sampat, ... Neuroimmunology & Neuroinflammation 2 (3), e102, 2015 | 233 | 2015 |
| Primary progressive multiple sclerosis evolving from radiologically isolated syndrome OH Kantarci, C Lebrun, A Siva, MB Keegan, CJ Azevedo, M Inglese, ... Annals of neurology 79 (2), 288-294, 2016 | 176 | 2016 |
| Radiologically Isolated Syndrome: 10‐Year Risk Estimate of a Clinical Event C Lebrun‐Frenay, O Kantarci, A Siva, MP Sormani, D Pelletier, DT Okuda, ... Annals of neurology 88 (2), 407-417, 2020 | 172 | 2020 |
| In vivo evidence of glutamate toxicity in multiple sclerosis CJ Azevedo, J Kornak, P Chu, M Sampat, DT Okuda, BA Cree, SJ Nelson, ... Annals of neurology 76 (2), 269-278, 2014 | 129 | 2014 |
| Body mass index, but not vitamin D status, is associated with brain volume change in MS EM Mowry, CJ Azevedo, CE McCulloch, DT Okuda, RR Lincoln, ... Neurology 91 (24), e2256-e2264, 2018 | 90 | 2018 |
| The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis P Bhargava, S Cassard, SU Steele, C Azevedo, D Pelletier, EA Sugar, ... Contemporary clinical trials 39 (2), 288-293, 2014 | 90 | 2014 |
| Contribution of normal aging to brain atrophy in MS CJ Azevedo, SY Cen, A Jaberzadeh, L Zheng, SL Hauser, D Pelletier Neurology: Neuroimmunology & Neuroinflammation 6 (6), e616, 2019 | 87 | 2019 |
| Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome DT Okuda, O Kantarci, C Lebrun‐Frénay, MP Sormani, CJ Azevedo, ... Annals of neurology 93 (3), 604-614, 2023 | 76 | 2023 |
| Imaging outcome measures of neuroprotection and repair in MS: a consensus statement from NAIMS J Oh, D Ontaneda, C Azevedo, EC Klawiter, M Absinta, DL Arnold, ... Neurology 92 (11), 519-533, 2019 | 72 | 2019 |
| Cervical spinal cord atrophy is an early marker of progressive MS onset B Zeydan, X Gu, MB Keegan, BG Weinshenker, D Pelletier, CJ Azevedo, ... MULTIPLE SCLEROSIS JOURNAL 22, 506-506, 2018 | 72 | 2018 |
| Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement D Ontaneda, PC Raza, KR Mahajan, DL Arnold, MG Dwyer, SA Gauthier, ... Brain 144 (7), 1974-1984, 2021 | 67 | 2021 |
| The radiologically isolated syndrome: revised diagnostic criteria C Lebrun-Frénay, DT Okuda, A Siva, C Landes-Chateau, CJ Azevedo, ... Brain 146 (8), 3431-3443, 2023 | 63 | 2023 |
| Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome C Lebrun-Frénay, F Rollot, L Mondot, H Zephir, C Louapre, E Le Page, ... JAMA Network Open 4 (10), e2128271-e2128271, 2021 | 58 | 2021 |
| Imaging chronic active lesions in multiple sclerosis: a consensus statement F Bagnato, P Sati, CC Hemond, C Elliott, SA Gauthier, DM Harrison, ... Brain, awae013, 2024 | 53 | 2024 |
| Intracerebral haemorrhage during alemtuzumab administration CJ Azevedo, C Kutz, A Dix, A Boster, N Sanossian, J Kaplan The Lancet Neurology 18 (4), 329-331, 2019 | 52 | 2019 |
| Longitudinal associations between brain structural changes and fatigue in early MS B Nourbakhsh, C Azevedo, J Nunan-Saah, AH Maghzi, R Spain, ... Multiple sclerosis and related disorders 5, 29-33, 2016 | 51 | 2016 |
| Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial C Lebrun-Frénay, A Siva, MP Sormani, C Landes-Chateau, L Mondot, ... JAMA neurology 80 (10), 1080-1088, 2023 | 41 | 2023 |
| Whole brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis? CJ Azevedo, D Pelletier Current Opinion in Neurology, 2016 | 37 | 2016 |
